Skip to main content

Publications

57 publications

Funding

10 grants

Active

1 grant
  • Sub-PI
    Longitudinal Follow up of Clinical Trial Participants For Brain Donation
    National Institute on Aging · 2023–2028 · via University of Southern California
    U24AG057437-06
Completed grants (9)
  • Sub-PI
    Brain Donation
    National Institute on Aging · 2022–2024 · via University of Southern California
    R01AG061848-03
  • Sub-PI
    A4-OLE - Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study
    National Institute on Aging · 2019–2023 · via University of Southern California
    R01AG063689-03
  • Sub-PI
    Tau PET Imaging for the USC Alzheimer's Therapeutic Research Institute (USC ATRI) A4 Trial (“A4 TAU”)
    Foundation for the National Institutes of Health, Inc. · 2015–2023 · via University of Southern California
    USC 16101659-03
  • Sub-PI
    Metformin in Alzheimer’s dementia Prevention (MAP)
    National Institute on Aging · 2019–2021 · via Columbia University
    R01AG062624-02
  • Co-I
    Understanding the dynamic interactions between tau pathology and microglia-mediated inflammation in Alzheimer's Disease
    National Institute on Aging · 2019–2021
    R56AG064873-01
  • Sub-PI
    Alzheimer’s Disease Cooperative Study – A4 Study
    National Institute on Aging · 2015–2020 · via University of Southern California
    U19AG010483-26
  • Sub-PI
    Effects of Traumatic Brain Injury and Post-Traumatic Stress Disorder on Alzheimer's Disease (AD) in Veterans With Mild Cognitive Impairment (MC) Using the Alzheimer's Disease Neuroimaging Initiative
    U.S. Department of Defense · 2015–2019 · via University of Southern California
    WEI1808-1916 EWOF
  • Sub-PI
    ADNI-DOD: Effects of Traumatic Brain Injury and Posttraumatic Stress Disorder On Alzheimer's Disease in Veterans Using ADNI
    U.S. Department of Defense · 2015–2019 · via University of Southern California
    WEI1808-1915
  • Sub-PI
    Effects of Traumatic Brain Injury and Post-Traumatic Stress Disorder and Alzheimer's Disease on Brain Tau in Vietnam Veterans Using ADNI
    U.S. Department of Defense · 2015–2018 · via University of Southern California
    WEI1872-06

Clinical research

1 study
Completed & closed trials (1)
  • PI
    Phase 3b Open-Label, Multicenter, Safety Study of BIIB037 (Aducanumab) in Subjects With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205
    PHASE3 · Biogen, Inc. · IRB STUDY CLOSURE (as of 2025)
    Alzheimer's Disease
    NCT04241068